While some consumer staples stocks have gone up more in the search for dividend yield, those stocks still have the private label specter hanging over them and will have continual sales volume pressure in the US and most likely in Europe as well. MJN should not have the pricing pressure as long as prices are not raised, which should make MJN a safer long-term holding than other staples stocks, many of which are overvalued at this point. But Mead Johnson?s 1.8% yield will not be competitive in the shorter term.
The stock had flirted with $81 but fell back to the low 70s when Chinese law changed -- it no longer allows individuals to buy large amounts of Mead?s formula in Hong Kong and take it to the mainland to resell. This sort of distributional curiosity was caused by a consumer overreaction to the sale of formula by domestic Chinese companies that had tainted domestic milk in it. This was about five years ago.? Mead?s Hong Kong formula is imported from The Netherlands, while its formula that is sold in mainland China is manufactured in China, but made from imported milk. A disproportionate amount of Chinese sales were being made via Hong Kong, so sales have been affected.
As a premier formula seller in China, I feel that it is just a matter of time, and some advertising, before sales are back to normal. The stock had been moving up on just that thought, I believe. Then the stock got to $81 after Danone (PINK:DANOY) reported strong formula sales in China and the Far East. Overall pricing was up 9% vs. the Street's expectation of 6%. That makes me feel better about the longer-term pricing level maintenance for Mead, though I would not raise my EPS growth rate for it.?
I would be somewhat leery, however, about the fact that some of the pricing taken by Danone, the No. 2 seller in China, may have come from sales problems at Mead. Danone just came out with some new products, but it also seems too easy to conclude that Mead?s sales adjustment from Hong Kong to mainland China formula has been discounted in one quarter.
Therefore, earnings to be reported on April 25 may be somewhat disappointing vs. the optimism engendered by the Danone report.
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
gone with the wind checkers imbibe msg network ray j anthony shadid gary carter
No comments:
Post a Comment